位置：成果数据库 > 期刊 > 期刊详情页
A solid-phase PEGylation strategy for protein therapeutics using a potent FGF21 analog.
  • ISSN号：0142-9612
  • 期刊名称：Biomaterials
  • 时间：2014.6
  • 页码：5206-5215
  • 相关项目：FGF21通过抑制GSK-3β活性对糖尿病心肌病的保护作用研究
作者： Song, Lintao|Zhu, Yanlin|Wang, Huiyan|Belov A. Artur|Niu, Jianlou|Shi, Lu|Xie, Yaoyao|Li, Xiaokun|Huang, Zhifeng|
同期刊论文项目
FGF21通过抑制GSK-3β活性对糖尿病心肌病的保护作用研究
期刊论文 7 会议论文 1 获奖 3
同项目期刊论文
A novel solid-phase site-specific PEGylation enhances the in vitro and in vivo biostabilty of r
Cracking the molecular origin of intrinsic tyrosine kinase activity through analysis of pathoge
Structural mimicry of a-loop tyrosine phosphorylation by a pathogenic FGF receptor 3 mutation.
One-step production of bioactive proteins through simultaneous PEGylation and refolding.
Solid-phase N-terminus PEGylation of recombinant human fibroblast growth factor 2 on heparin-se
Fibroblast growth factor 21 protects the diabetic heart from cell death via extracellular signal-reg